US Stock MarketDetailed Quotes

RENB Renovaro

Watchlist

0.551
+0.041+8.04%

Close Oct 14 16:00 ET

0.558
+0.007+1.31%

Post 17:39 ET

86.06MMarket Cap-655P/E (TTM)

Renovaro Stock Forum

Stock_Drift

Oct 6 06:27

Monday_10/7/24 Earnings.

$The Duckhorn Portfolio (NAPA.US)$ $Renovaro (RENB.US)$ $Upexi (UPXI.US)$

Stock_Drift

Oct 3 15:39

After Hours Ticks. 10/3…4:47pm EST.

$Intellinetics (INLX.US)$ $Lm Funding America (LMFA.US)$ $Beyond Air (XAIR.US)$ $Jianzhi Education (JZ.US)$ $China Jo-Jo Drugstores (CJJD.US)$ $Martin Midstream (MMLP.US)$ $Edesa Biotech (EDSA.US)$ $AIM ImmunoTech (AIM.US)$ $Smart Sand (SND.US)$ $SPI Energy (SPI.US)$ $Renovaro (RENB.US)$ $Phoenix Motor (PEV.US)$

Trytosaveabit

Oct 3 15:07

Hmm

$Renovaro (RENB.US)$ 🤔

Trytosaveabit

Sep 19 08:07

Update

$Renovaro (RENB.US)$ NASDAQ:RENB) PersonalAIze and RenovaroCube are proud to announce a strategic partnership to develop, validate, and commercialize Cube's AI-driven, multi-omic platform for early detection of cancer and other diseases. This strategic partnership aims to provide services to many AI companies and healthcare systems while also creating the next generation of medical diagnostics through cutting-edge AI by driving greater accuracy, transparency, and trust in healthcare solutio...

Update

$Renovaro (RENB.US)$ Independent Expert Assessment Validates RenovaroCube's Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection
Globe Newswire 17-Sep-2024 9:00 AM

$Renovaro (RENB.US)$ LOS ANGELES and AMSTERDAM, May 24, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ:RENB) and the Amsterdam UMC Cancer Center today announced an intended partnership and therefore signed an MoU to establish a joint company based in the Netherlands aimed at pioneering the next generation of personalized cancer immunotherapy. Both Renovaro and Amsterdam UMC emphasize the need to carry out the appropriate corporate and scientific due diligence before taking these next s...